LEO Pharma

LEO Pharma, Japan Tobacco ink license agreement for JTE-052

Wednesday, November 5, 2014 12:47 PM

LEO Pharma and Japan Tobacco (JT) have entered into a license agreement, under which LEO Pharma will obtain exclusive rights to further develop, register and market JT’s experimental JAK inhibitor, JTE-052, for topical use in dermatological indications worldwide, excluding Japan where JT retains rights.

More... »


LEO Pharma, 4SC Discovery ink exclusive research agreement

Tuesday, February 26, 2013 01:48 PM

LEO Pharma, a global pharmaceutical company specializing in dermatology, has entered into an exclusive research and license agreement with the German biotech company 4SC Discovery with the primary aim of jointly researching, developing and commercializing an oral treatment for inflammatory skin diseases such as psoriasis.

More... »


LEO Pharma unveils new scientific collaboration strategy

Wednesday, October 3, 2012 11:08 AM

LEO Pharma, a global pharmaceutical company specializing in dermatology and critical care, plans to establish five long-term, strategic research collaborations in Australia, France, Germany and the U.S. by the end of next year.

More... »

FDA approves LEO Pharma’s Picato gel

Wednesday, January 25, 2012 04:21 PM

The FDA has approved LEO Pharma’s Picato (ingenol mebutate) gel (0.015%, 0.05%) for the topical treatment of actinic keratosis (AK), a precancerous condition caused by cumulative sun exposure.

More... »

LEO Pharma and Scripps Research Institute collaborate

Tuesday, July 19, 2011 01:39 PM

LEO Pharma and The Scripps Research Institute have entered a research collaboration.

More... »

CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 15

Cancer Treatment Centers of America chooses WCG as its exclusive IRB, sheds five local hospital IRBs

Five southern research groups form public-private network to help save time, money for clients with early-stage biologics

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

December

Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs